To direct the Director of the National Institutes of Health and the Secretary of Health and Human Services to evaluate hormone variability and hormone testing, respectively, in women with respect to perimenopause.
Last action: 5-29-2026
Version: 2026012515
Current status: Referred to the House Committee on Energy and Commerce.